Nice to see results like this from the Cherokee Nation Health Services : Clinical Pharmacist + Intensive #Diabetes Management Service + personal CGM = nuking of A1c
(Poster presented at the SDPI 2024 Grantee Conference
#IHSGov #HHSGov)
Feeling great seeing our own experience at #UNMHSC #UNMHospital integrating clinician pharmacists for intensive diabetes mgmt + CMG validated by other groups!
Nice to see results like this from the Cherokee Nation Health Services : Clinical Pharmacist + Intensive #Diabetes Management Service + personal CGM = nuking of A1c
(Poster presented at the SDPI 2024 Grantee Conference
#IHSGov #HHSGov)
Feeling great seeing our own experience at #UNMHSC #UNMHospital integrating clinician pharmacists for intensive diabetes mgmt + CMG validated by other groups!
Very touching article about ECMO (Extra Corporeal Membrane Oxygenation) and its role in critical illness. Powerful summary of the ECMO program at my institution
#UNMHSC
#UNMHospital #UNM
for victims of cardiac arrest under Jon Marinaro.
https://www.newyorker.com/science/annals-of-medicine/how-ecmo-is-redefining-death
Diabetic Kidney Disease in Post-Kidney Transplant Patients https://www.mdpi.com/2658854
Coauthored by Dr Pablo Garcia MD, Dr Yen Pham PharmD & our fellows Dr Raja Ravender MD & Luis Madera MD at #UNMHSC Nephrology
Always great to collaborate with our pharmacy colleagues in papers!
Post-transplant diabetes mellitus (PTDM) is a common occurrence in post-kidney transplantation and is associated with greater mortality, allograft failure, and increased risk of infections. The primary goal in the management of PTDM is to achieve glycemic control to minimize the risk of complications while balancing the need for immunosuppression to maintain the health of the transplanted kidney. This review summarizes the effects of maintenance immunosuppression and therapeutic options among kidney transplant recipients. Patients with PTDM are at increased risk of diabetic kidney disease development; therefore, in this review, we focus on evidence supporting the use of novel antidiabetic agents and discuss their benefits and potential side effects in detail.
Diabetic Kidney Disease in Post-Kidney Transplant Patients https://www.mdpi.com/2658854
Coauthored by Dr Pablo Garcia MD, Dr Yen Pham PharmD & our fellows Dr Raja Ravender MD & Luis Madera MD at #UNMHSC Nephrology
Always great to collaborate with our pharmacy colleagues in papers!
Post-transplant diabetes mellitus (PTDM) is a common occurrence in post-kidney transplantation and is associated with greater mortality, allograft failure, and increased risk of infections. The primary goal in the management of PTDM is to achieve glycemic control to minimize the risk of complications while balancing the need for immunosuppression to maintain the health of the transplanted kidney. This review summarizes the effects of maintenance immunosuppression and therapeutic options among kidney transplant recipients. Patients with PTDM are at increased risk of diabetic kidney disease development; therefore, in this review, we focus on evidence supporting the use of novel antidiabetic agents and discuss their benefits and potential side effects in detail.
Our #Nephrology #fellowship program webpage at #UNM #UNMHSC has been updated (kudos to @nephcrit_nm our PD who brought the project to completion!).
Surf the wave to see what we offer for subspecialty training in Nephrology 👇
https://hsc.unm.edu/medicine/departments/internal-medicine/academic-divisions/nephrology/fellowship.html
Christos Argyropoulos MD PhD
Christos Argyropoulos MD, PhD